NFKB1 and cancer: It also downregulates NF-κB activation, which is crucial for inflammation-associated tumor progression, and modulates the Wnt/β-catenin pathway, thereby reducing cancer stem cell properties and tumorigenesis (Rahmani et al., 2022; Yan et al., 2017).